IAN T. BOTHWELL - 13 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
13 May 2021
Transactions value $
-$40,800
Form type
4
Filing time
17 May 2021, 21:45:30 UTC
Previous filing
12 May 2021
Next filing
25 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale -$13.5K -50K -0.03% $0.27 150M 13 May 2021 Direct
transaction OCEL Common Stock Sale -$12K -50K -0.03% $0.24 150M 14 May 2021 Direct
transaction OCEL Common Stock Sale -$10.3K -50K -0.03% $0.21 150M 17 May 2021 Direct
transaction OCEL Common Stock Sale -$5K -25K -0.02% $0.20 150M 17 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.